Tag: Dr. Zohar Koren

November 6, 2018

FSD Pharma Announces Positive ISA Report for “Steady Stomach” CBD Combination

FSD Pharma Inc, (CSE:HUGE) announced today that its strategic R&D partner, SciCann Therapeutics Inc. (“SciCann”) received a positive International Search...
October 15, 2018

FSD Pharma and SciCann Therapeutics to Attend the CannX International Medical Cannabis Convention in Tel Aviv Israel

FSD Pharma Inc, (CSE:HUGE) ("FSD Pharma") is pleased to announce that its Head of Scientific Advisory Board, Dr. Zohar Koren,...